NCT04549740View on ClinicalTrials.gov

The Role of Salivary Alpha Amylase in Sepsis

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

February 20, 2024

Study Completion Date

March 1, 2024

Conditions
Sepsis
Interventions
DIAGNOSTIC_TEST

salivary alpha amylase level measurement

Saliva samples will be obtained to estimate salivary alpha amylase

Trial Locations (1)

31527

Tarek Abdel Hay, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT04549740 - The Role of Salivary Alpha Amylase in Sepsis | Biotech Hunter | Biotech Hunter